Tuesday, August 27, 2013

Eli Lilly announces appointment of Mr. Edgard Olaizola as the new Managing Director for India operations

Eli Lilly announces appointment of Mr.  Edgard Olaizola as the new Managing Director for India operations
Mumbai, 27th August 2013 – Eli Lilly and Company India (Lilly), announces the appointment of Mr. Edgard Olaizola as its new Managing Director, overseeing Lilly’s operations in India and Srilanka with effect from September 1, 2013.

Mr. Olaizola will succeed Mr. Melt Van Der Spuy, the current Managing Director, Lilly India, who has been promoted to the position of Vice President, Emerging Markets (Latin America and Asia Pacific) for Elanco Animal Health (fully owned subsidiary of Eli Lilly and company).
Mr. Olaizola brings with him over 13 years of diversified experience in Lilly, with a host of senior level positions to his credit across different markets, including US, Canada, Peru, Ecuador and Bolivia. His last role was as General Manager, Lilly Taiwan, where Mr. Olaizola played a crucial role in making Lilly Taiwan as one of the best performing countries for Lilly in Asia region.
Commenting on his appointment, Mr. Edgard Olaizola said, “I am delighted to be a part of Lilly India team. India is one of the key markets for Lilly in Asia, with an immense opportunity to positively impact the lives of patients with our quality products and services. I am excited to continue Lilly’s journey to success in one of the most dynamic markets in the world.”
Mr. Edgard Olaizola holds a degree in Economics from Universidad Catolica Andres Bello and has completed his Post Graduation in Business Management from Washington University in St. Louis.
About Eli Lilly and Company
Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Indiana, Lilly provides answers – through medicines and information – for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

No comments:

Post a Comment